tesamorelin inn trade name egrifta sv synthetic form growthhormonereleasing hormone ghrh used treatment hivassociated lipodystrophy approved initially produced developed theratechnologies inc canada drug synthetic peptide consisting amino acids human ghrh addition acid tesamorelin nterminally modified compound based amino acids sequence human modified synthetic form potent stable natural peptide also resistant cleavage dipeptidyl aminopeptidase human stimulates synthesis release endogenous gh increase level insulinlike growth factor released gh binds receptors present various body organs regulates body composition regulation mainly combination anabolic lipolytic mechanisms however found main mechanisms tesamorelin reduces body fat mass lipolysis followed reduction triglycerides tesamorelin therapy may cause glucose intolerance increase risk type contraindicated also contraindicated pregnancy category x may cause harm fetus also contraindicated patients affected hypothalamicpituitary axis disruption due pituitary gland tumor head irradiation injection site erythema peripheral edema injection site pruritus hormonal preparation article stub help wikipedia expanding httpsenwikipediaorgwikitesamorelin